Our Patent Litigation team is a proud partner to the world’s most innovative life sciences and technology companies. Our experience successfully handling high-stakes patent matters, joined with Paul, Weiss's legendary litigation capabilities, enable us to provide comprehensive strategies to protect our clients’ most valuable innovations that extend well beyond traditional patent litigation.
Firm News
Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York
Elizabeth “Liz” Stotland Weiswasser and Anish R. Desai will join the firm as partners in its Litigation Department, resident in New York. Liz, who will be co-chair of the Litigation Department, and Anish are nationally recognized for their success representing life sciences and technology clients in their most significant complex commercial disputes.
» morePublications
Liz Weiswasser Discusses Her Team’s Lateral Move to Paul, Weiss in The American Lawyer
Litigation Co-Chair Liz Weiswasser spoke with The American Lawyer about her lateral move to Paul, Weiss with litigation partner Anish Desai and their work to bring over 18 other colleagues in the weeks that followed.
» moreAwards & Recognition
Bloomberg Law Lists Arrivals of Liz Weiswasser, Anish Desai and Jim Langston Among Top Lateral Moves of 2024
The arrivals of Paul, Weiss Litigation Department Co-Chair Liz Weiswasser and litigation partner Anish Desai, and corporate partner Jim Langston were featured by Bloomberg Law as among the 11 most notable lateral moves in Big Law this year.
» moreAwards & Recognition
Paul, Weiss Shortlisted in Three Categories for LMG Life Sciences Americas Awards
Paul, Weiss is shortlisted in three categories in LMG Life Sciences’ 2022 LMG Life Sciences Americas Awards. The firm is a contender for “General Patent Litigation Firm of the Year.”
» moreClient News
Genentech Wins Summary Judgment in Patent Dispute Over Hemophilia A Drug
See Also
Paul, Weiss won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough hemophilia treatment HEMLIBRA® (emicizumab).
» morePublications
Intellectual Property Litigation: Distinguishing Unexpected Results In Evaluating Non-Obviousness
Litigation partners Catherine Nyarady and Crystal Parker’s latest Intellectual Property Litigation column, “Distinguishing Unexpected Results In Evaluating Non-Obviousness,” appeared in the July 12 issue of the New York Law Journal.
» moreAwards & Recognition
Paul, Weiss Life Sciences Practice Named Law360 “Practice Group of the Year”
Paul, Weiss won Law360 “Practice Group of the Year” recognition for its achievements in 2021 in the Life Sciences category.
» moreClient News
Edwards Lifesciences Wins Court Victory in Patent Dispute Over Heart Valve Repair Device
See Also
Paul, Weiss won a significant victory for Edwards Lifesciences in patent litigation brought by Abbott Laboratories concerning Edwards’ PASCAL, an important new medical device recently approved for use in Europe to treat a common form of often-fatal heart disease called mitral regurgitation.
» more